Pharma Giant Expands with Strategic Acquisition in Singapore
Pharma Giant Expands with Strategic Acquisition in Singapore

Pharma Giant Expands with Strategic Acquisition in Singapore

The company has a strong presence in regulated markets such as the United States and Europe and is a leading producer of niche generic formulations.

DSIJ Intelligence Article rating: 4.0

The company has been actively expanding its product pipeline, with over 70 commercialized products and a healthy pipeline of 100+ approved products.

Rakesh Jhunjhunwala’s portfolio gains 19,19,23,388.25 in just 1 day: Multibagger pharma stock locked in upper circuit on March 19
Rakesh Jhunjhunwala’s portfolio gains 19,19,23,388.25 in just 1 day: Multibagger pharma stock locked in upper circuit on March 19

Rakesh Jhunjhunwala’s portfolio gains 19,19,23,388.25 in just 1 day: Multibagger pharma stock locked in upper circuit on March 19

The stock gave multibagger returns of 160 per cent in just 1 year whereas BSE Sensex Index is up by 5 per cent.

DSIJ Intelligence Article rating: 3.6

The stock’s 52-week high is Rs 1,678.60 per share while its 52-week low is Rs 489.20 per share.

Strategic Acquisition: Major MedTech Expansion by Indian Pharma Giant
Strategic Acquisition: Major MedTech Expansion by Indian Pharma Giant

Strategic Acquisition: Major MedTech Expansion by Indian Pharma Giant

Zydus Lifesciences Limited has announced its strategic decision to acquire a controlling stake in Amplitude Surgical SA, a France-based company listed on Euronext Paris.

DSIJ Intelligence Article rating: 3.3

Zydus Lifesciences Limited, a prominent player in the Indian pharmaceutical sector, is currently trading at a stock price of Rs 900 with a market capitalization of over Rs 90,000 crores.

New Diabetes Drug Launched: Affordable Treatment Revolution in India
New Diabetes Drug Launched: Affordable Treatment Revolution in India

New Diabetes Drug Launched: Affordable Treatment Revolution in India

Alkem's commitment to global health improvement is reflected in its diverse product offerings and international presence.

DSIJ Intelligence Article rating: 5.0

Alkem Laboratories Ltd. is a prominent Indian pharmaceutical company known for its high-quality medicines over the past 50 years.

Pharma stock under Rs 70 jumps 11.5%; Unico Global Opportunities Fund bought 45,77,717 shares & Ebisu Global Opportunities Fund bought 45,21,028 shares
Pharma stock under Rs 70 jumps 11.5%; Unico Global Opportunities Fund bought 45,77,717 shares & Ebisu Global Opportunities Fund bought 45,21,028 shares

Pharma stock under Rs 70 jumps 11.5%; Unico Global Opportunities Fund bought 45,77,717 shares & Ebisu Global Opportunities Fund bought 45,21,028 shares

The company has a market cap of over Rs 300 crore and the stock is up by 24.1 per cent from its 52-week low of Rs 50.42 per share.

DSIJ Intelligence Article rating: 5.0

The company has a market cap of over Rs 300 crore and the stock is up by 24.1 per cent from its 52-week low of Rs 50.42 per share.

DSIJ MINDSHARE

Mkt Commentary2-Apr, 2025

Mkt Commentary2-Apr, 2025

Multibaggers2-Apr, 2025

Mindshare2-Apr, 2025

Mindshare2-Apr, 2025

Knowledge

General22-Mar, 2025

MF14-Mar, 2025

MF14-Mar, 2025

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR